apollo
logo
0Login
Introducing Our Latest Arrival!
Hepcdac 60Mg Tablet 28'S

Hepcdac 60Mg Tablet 28'S

Prescription drug
 Trailing icon
Consult Doctor

Composition

DACLATASVIR-60MG

Manufacturer/Marketer

Cipla Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Hepcdac 60Mg Tablet

Hepcdac 60Mg Tablet is an antiviral medicine used along with sofosbuvir, with or without ribavirin, to treat chronic hepatitis C viral genotype 1 or 3 infection. It is a serious infection caused by the hepatitis C virus. It is a contagious infection that spreads from person to person and affects the liver. Hepcdac 60Mg Tablet is only used in treating the infection. It does not cure or prevent further liver complications.

Hepcdac 60Mg Tablet contains Daclatasvir, which belongs to the class of hepatitis C virus (HCV) NS5A inhibitors. It works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and reduces the amount of hepatitis C virus in the body.

Hepcdac 60Mg Tablet may cause certain side effects such as headache, fatigue, weakness, confusion, chest pain, nausea, diarrhoea, shortness of breath, dizziness and lightheadedness. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. Use it as suggested by your doctor. Your doctor will decide the duration of the medicine based on your health condition.

Hepcdac 60Mg Tablet should be avoided if you are allergic to it. If you are pregnant or breastfeeding, inform your doctor before starting treatment with this medicine. Hepcdac 60Mg Tablet is not recommended for children below 18 years of age as efficacy and safety have not been established. Inform your doctor if you have any underlying conditions like hepatitis B virus infection, liver cirrhosis, nephrotoxicity, liver transplant, heart problem, kidney problems, or HIV infection, as it may cause serious side effects. Hepcdac 60Mg Tablet may cause hepatitis B infection reactivation and bradycardia (slow heart rate) in some patients. Hence, patients should be monitored carefully for any changes.

Uses of Hepcdac 60Mg Tablet

Treatment of Hepatitis C virus infection

Medicinal Benefits

Hepcdac 60Mg Tablet contains Daclatasvir, which belongs to the class of hepatitis C virus (HCV) NS5A inhibitors. It works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and, therefore, reduces the amount of hepatitis C virus in the body.

Directions for Use

Swallow the tablet as a whole with a glass of water. Do not chew, break or crush the tablet.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Hepcdac 60Mg Tablet

  • Headache
  • Chest Pain
  • Nausea
  • Diarrhoea
  • Shortness of breath
  • Dizziness
  • Fatigue
  • Light-headedness
  • Weakness

Drug Warnings

Hepcdac 60Mg Tablet should be avoided if you are allergic to it. If you are pregnant or breastfeeding, inform your doctor before starting treatment with this medicine. Hepcdac 60Mg Tablet is not recommended for children below 18 years of age as efficacy and safety have not been established. Inform your doctor if you have any underlying conditions like hepatitis B virus infection, liver cirrhosis, nephrotoxicity, liver transplant, heart problem, other kidney problems, or HIV infection, as it may cause serious side effects. Hepcdac 60Mg Tablet may cause hepatitis B infection reactivation and bradycardia in some patients. Hence, patients should be monitored carefully for any changes.

Drug Interactions

Drug-Drug Interactions: Hepcdac 60Mg Tablet may interact with a antifungal drugs (ketoconazole, voriconazole), antibiotics (clarithromycin, telithromycin), cholesterol-lowering medicines (atorvastatin, pitavastatin), narcotic analgesics (buprenorphine, naloxone), antiviral drugs (atazanavir, nelfinavir, indinavir), antiarrhythmic drug (amiodarone), anticoagulant drugs (dabigatran, warfarin), CYP3A inducers (phenytoin, carbamazepine, phenobarbitone, rifampin).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Inform your doctor if you have any history of liver or kidney disease or HIV/AIDS infection.

Drug-Drug Interactions Checker List

  • AMIODARONE
  • KETOCONAZOLE
  • VORICONAZOLE
  • DABIGATRAN
  • WARFARIN
  • ATAZANAVIR
  • NELFINAVIR
  • NALOXONE
  • BUPRENORPHINE
  • ATORVASTATIN
  • PRAVASTATIN
  • PHENYTOIN
  • PHENOBARBITONE
  • RIFAMPICIN
  • CARBAMAZEPINE

Habit Forming

No

Diet & Lifestyle Advise

  • Eat more vegetables, fruits, and whole grains such as brown rice, oats, quinoa, and barley.
  • Include healthy fats like avocados, olive oil, and nuts.
  • Drink plenty of water for better processing of food by the body.
  • Avoid sugary foods such as cake, cookies, packaged baked food, or soda. Also, avoid heavy salt foods.
  • Avoid foods containing saturated fats such as fried foods, fatty cuts of meat, sour cream, and butter.
  • Try to eat low-fat or non-fat dairy products to minimise damage to the liver.

Special Advise

  • Close monitoring of liver and kidney function tests is required while on treatment with Hepcdac 60Mg Tablet to monitor liver and kidney functions.
  • Sudden withdrawal of Hepcdac 60Mg Tablet should be avoided as it can cause severe acute exacerbations of hepatitis or other serious side effects.

Disease/Condition Glossary

Hepatitis C Virus Infection: It is a contagious infection caused by the hepatitis C virus affecting the liver. This infection spreads from person to person through blood contact (being pricked with a contaminated needle or using a razor), intimate contact with the infected person, direct contact with infected blood, or contact with any other personal items with leftovers of infected fluid or even from mother to baby during birth. The symptoms may not appear immediately. Some may take between 2 to 12 weeks to appear. Few people may have mild to moderate symptoms such as dark urine, loss of appetite, fever, joint pain, or stomach discomfort. The complications of untreated chronic hepatitis C include liver cancer or liver cirrhosis (scarring).

bannner image

Alcohol

Consult your doctor

It is not known if Hepcdac 60Mg Tablet interacts with alcohol. Please consult your doctor.

bannner image

Pregnancy

Caution

If you are pregnant or planning pregnancy, inform your doctor before taking Hepcdac 60Mg Tablet . Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

If you are a nursing mother, inform your doctor before taking Hepcdac 60Mg Tablet . Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Driving

Consult your doctor

It is not known if Hepcdac 60Mg Tablet affects your ability to drive. Do not drive or operate heavy machinery if you are not alert.

bannner image

Liver

Caution

If you have a history of liver disease, inform your doctor before taking Hepcdac 60Mg Tablet . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Kidney

Caution

If you have a history of kidney disease, inform your doctor before taking Hepcdac 60Mg Tablet . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

Hepcdac 60Mg Tablet is not recommended for use in children below 18 years of age, as efficacy and safety have not been established.

Country of origin

India

Manufacturer/Marketer address

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Other Info - HEP0254

FAQs

Hepcdac 60Mg Tablet is used to treat Hepatitis C virus infection.
Hepcdac 60Mg Tablet contains Daclatasvir, which works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and reduces the amount of hepatitis C virus in the body.
Avoid receiving Hepcdac 60Mg Tablet if you are allergic to it or other medicines of the same class. Also, this medicine should not be used along with CYP3A inducer drugs such as rifampicin, carbamazepine, phenytoin, etc., as it can cause serious adverse effects. Concomitant use of Hepcdac 60Mg Tablet along with amiodarone should be avoided due to the risk of severe bradycardia (slow heart rate).

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.